Development Level

Tchem 5 | 1,890
Tbio 4 | 10,625
Tclin 3 | 602

IMPC Term

preweaning lethality, complete... 2 | 633
abnormal cornea morphology 1 | 24
corneal opacity 1 | 25
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased grip strength 1 | 123
decreased kidney weight 1 | 7
decreased lean body mass 1 | 195
decreased leukocyte cell numbe... 1 | 54
decreased spleen weight 1 | 13
embryonic lethality prior to t... 1 | 187
impaired glucose tolerance 1 | 52
impaired pupillary reflex 1 | 14
increased circulating HDL chol... 1 | 63
increased total body fat amoun... 1 | 57
limb grasping 1 | 35
narrow eye opening 1 | 15

Disease

Cancer 7 | 2,346
Carcinoma 6 | 2,147
atypical teratoid / rhabdoid tumor 6 | 4,369
malignant mesothelioma 6 | 3,162
ovarian cancer 6 | 8,484
psoriasis 6 | 6,685
Colorectal Neoplasms 5 | 217
Mammary Neoplasms 5 | 410
Prostatic Neoplasms 5 | 471
glioblastoma 5 | 5,572
interstitial cystitis 5 | 2,299
medulloblastoma, large-cell 5 | 6,234
posterior fossa group A ependymoma 5 | 1,511
Endometriosis 4 | 535
astrocytic glioma 4 | 2,241
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
invasive ductal carcinoma 4 | 2,950
lung cancer 4 | 4,466
lung carcinoma 4 | 2,844
osteosarcoma 4 | 7,933
pilocytic astrocytoma 4 | 3,086
pituitary cancer 4 | 1,972
Adenocarcinoma 3 | 115
Alzheimer's disease 3 | 644
Blastic phase chronic myeloid leukemia 3 | 58
Breast cancer 3 | 3,094
Chronic Myelocytic Leukemia Accelerated Phase 3 | 59
Chronic phase chronic myeloid leukemia 3 | 45
Cleft palate 3 | 125
Diabetic Nephropathy 3 | 37
Hypertension 3 | 287
Hypospadias 3 | 65
Liver carcinoma 3 | 217
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 3 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 3 | 47
breast carcinoma 3 | 1,614
esophageal adenocarcinoma 3 | 737
gastric carcinoma 3 | 832
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
juvenile dermatomyositis 3 | 1,189
lung adenocarcinoma 3 | 2,713
non-small cell lung cancer 3 | 2,798
non-small cell lung carcinoma 3 | 413
oligodendroglioma 3 | 2,849
pancreatic cancer 3 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
pediatric high grade glioma 3 | 2,712
primary pancreatic ductal adenocarcinoma 3 | 1,271
spina bifida 3 | 1,064
Acrocephalosyndactylia 2 | 15
Acute kidney injury 2 | 65
Adenoma 2 | 165
Atherosclerosis 2 | 275
Becker muscular dystrophy 2 | 187
Carcinoma of thyroid 2 | 17
Cerebrovascular disease 2 | 231
Cleft Lip 2 | 91
Congenital diaphragmatic hernia 2 | 43
Coronary artery disease 2 | 240
Craniosynostosis 2 | 47
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Diabetic Retinopathy 2 | 53
Diarrhea 2 | 155
Duchenne muscular dystrophy 2 | 602
Esophageal Neoplasms 2 | 67
Esophageal atresia 2 | 25
Exanthem 2 | 39
Heart disease 2 | 279
Hypertensive disease 2 | 193
IGA Glomerulonephritis 2 | 454
Inflammation 2 | 109
Kidney disease 2 | 396
Lung Neoplasms 2 | 171
Malaria 2 | 140
Malignant neoplasm of prostate 2 | 67
Neoplasm Invasiveness 2 | 127
Neoplasm Metastasis 2 | 138
Neoplasm Recurrence, Local 2 | 23
Neutropenia 2 | 78
Obesity 2 | 616
Pancreatic Neoplasm 2 | 79
Papilloma 2 | 27
Peripheral vascular disease 2 | 90
Pick disease 2 | 1,893
Prostate cancer 2 | 172
Proteinuria 2 | 63
Spontaneous abortion 2 | 108
Squamous cell carcinoma 2 | 94
Uremia 2 | 19
cutaneous lupus erythematosus 2 | 1,056
cystic fibrosis 2 | 1,665
diabetes mellitus 2 | 1,663
ductal carcinoma in situ 2 | 1,745
group 4 medulloblastoma 2 | 1,875
medulloblastoma 2 | 1,524
sarcoidosis 2 | 358
subependymal giant cell astrocytoma 2 | 2,287
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087

Tissue

Blood and immune system 12 | 17,995
Cardiovascular System 12 | 17,958
Digestive Tract 12 | 18,473
Endocrine System 12 | 18,512
Female tissues 12 | 18,647
Liver and Pancreas 12 | 18,136
Male tissues 12 | 17,969
Nervous System 12 | 18,561
Respiratory system 12 | 17,484
Skin and soft tissues 12 | 18,115
Urinary Tract 12 | 18,444

Target Family

Non-IDG 6 | 11,971
Kinase 5 | 634
Nuclear Receptor 1 | 48

Grant Application

5P30AR041943-07 12 | 12
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Fibroblast growth factor 10 FGF10 Tbio Non-IDG -2.51373 345.1 271
Ephrin-B1 EFNB1 Tbio Non-IDG -2.22021 187.7 305
Transforming growth factor beta-1 TGFB1 Tchem Non-IDG -4.32707 20956.6 961
Ephrin type-B receptor 1 EPHB1 Tchem Kinase -1.64016 48.2 364
Ephrin type-B receptor 4 EPHB4 Tchem Kinase -2.19619 184.7 435
Epidermal growth factor receptor EGFR Tclin Kinase -3.95948 9318.1 4989